Marex (MRX) Cash & Equivalents (2022 - 2026)

Marex (MRX) has 5 years of Cash & Equivalents data on file, last reported at $3.1 billion in Q1 2026.

• Quarterly Cash & Equivalents rose 17.73% year-over-year to $3.1 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.1 billion (up 17.73% YoY) and the FY2025 annual result came in at $2.9 billion, up 12.7% from the prior year.
• Cash & Equivalents grew to $3.1 billion in Q1 2026, from $2.9 billion in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $3.4 billion in Q2 2025 to a low of $910.1 million in Q4 2022.
• A 5-year average of $2.4 billion and a median of $2.6 billion in 2025 frame the typical range for Cash & Equivalents.
• The widest YoY moves for Cash & Equivalents: up 76.33% in 2025, down 12.7% in 2025.
• Tracing MRX's Cash & Equivalents over 5 years: stood at $910.1 million in 2022, then soared by 63.0% to $1.5 billion in 2023, then soared by 72.34% to $2.6 billion in 2024, then gained by 12.7% to $2.9 billion in 2025, then gained by 6.51% to $3.1 billion in 2026.
• The last three Cash & Equivalents figures came in at $3.1 billion (Q1 2026), $2.9 billion (Q4 2025), and $3.1 billion (Q3 2025), per Business Quant data.